Under the terms of the agreement, the NxStage System One and PureFlow SL dialysate preparation system will be available to dialysis centers throughout the Netherlands exclusively through Dirinco.

Dirinco will also make System One available for use in critical care applications, and has the option to make NxStage Medisystems ButtonHole needles available to its customers in this region.

John Mullen, vice president and general manager international at NxStage Medical, said: “We are pleased to announce this new opportunity to provide more patients access to our life-changing products while expanding our international presence. We look forward to working closely with Dirinco, a company with a long history of successfully introducing new technologies and therapies to the Dutch market.”

Roel Kuiper, managing director of Dirinco, said: “As many dialysis patients in this region seek alternative treatments to in-center dialysis, we believe there is a real opportunity to advance home hemodialysis in the Netherlands. Through our agreement with NxStage, our customers will gain access to this innovative technology and the quality of life and clinical benefits daily therapy with the System One has been reported to offer.”

The Dutch Dirinco Group, with subsidiaries in Belgium and Switzerland (Citra-Lock), is a company with products and services mainly in the areas of chronic and acute hemodialysis.